Type A Influenza Articles & Analysis
7 news found
Influenza A viruses exhibit a remarkable ability to mutate and evolve, producing multiple subtypes and antigenic variants. ...
At EnGen Bio, we believe the development of a universal vaccine for type A flu is in sight. Even prior to the emergence of COVID-19, we have been pursuing a universal immune strategy against type A influenza (the most common and deadly form of seasonal and pandemic flu in both humans and animals), and we have discovered what we believe to be the ...
EnGen Bio is an early stage biotechnology company developing a new approach to preventing and treating all Type A influenza strains—including all flu pandemics. Seasonal flu causes 50,000–250,000 deaths worldwide annually, causing the World Health Organization to declare the development of a universal flu vaccine as an urgent need in its Global ...
Though the SARS-CoV-2 virus (which causes COVID-19) is straining global resources, its rate of mortality is actually far lower than that seen in cases of exposure to some other influenza viruses. The Spanish flu pandemic affected a staggering number of global citizens, with more than 50 million deaths documented worldwide. ...
EnGen Bio is an early stage biotechnology company pioneering a new approach to preventing and treating influenza, with the goal of an effective, easy-to-manufacture, shelf-stable universal flu vaccine that should confer long-term immunity to all Type A influenza strains—including all flu pandemics. ...
It is intended for the qualitative detection of influenza type A and type B nucleoprotein antigens directly from nasal or nasopharyngeal swab specimens from patients with signs and symptoms of respiratory infection. “The CE Marking of the OSOM® Ultra Plus Flu A&B Test expands our flu portfolio allowing us to provide a more accurate ...
The new Vitassay SARS-CoV-2 + Flu A + B + RSV + Adeno Resp. is a rapid, immunochromatographic assay for the simultaneous qualitative detection of nucleoprotein antigen of SARS-CoV-2, Influenza type A, Influenza type B, RSV and Adenovirus from nasopharyngeal swabs samples from patients suspected of COVID-19 infection and/or ...